Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 24 citing articles:

Neuropathogenesis-on-chips for neurodegenerative diseases
Sarnai Amartumur, Huong Mai Nguyen, Thuy Huynh, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 26
Molecular hallmarks of ageing in amyotrophic lateral sclerosis
Cyril J. Jagaraj, Sina Shadfar, Sara Assar Kashani, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 11
The Role of Epigenetics in Neuroinflammatory-Driven Diseases
Sebastiano Giallongo, Lucia Longhitano, Simona Denaro, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 15218-15218
Open Access | Times Cited: 33
Neuroimmune Crosstalk Between the Peripheral and the Central Immune System in Amyotrophic Lateral Sclerosis
Weiyi Yu, Ji He, Xiying Cai, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 25
Image-guided monitoring of mitochondria and blood-brain barrier dysfunction in amyotrophic lateral sclerosis mice
Do Won Hwang, Jinhui Ser, Konstantyn Ziabrev, et al.
Biomaterials Research (2025) Vol. 29
Open Access
Frontotemporal dementia
Shaimaa Nasr Amin, Ahmed Bassam Mohd, Carla Ammar Samain, et al.
Elsevier eBooks (2024), pp. 131-146
Closed Access | Times Cited: 2
Small molecules targeting different cellular pathologies for the treatment of amyotrophic lateral sclerosis
Mohamed F. El‐Mansy, Cory T. Reidl, Mizzanoor Rahaman, et al.
Medicinal Research Reviews (2023) Vol. 43, Iss. 6, pp. 2260-2302
Open Access | Times Cited: 6
Inflammatory checkpoints in amyotrophic lateral sclerosis: From biomarkers to therapeutic targets
Zongzhi Jiang, Ziyi Wang, Xiaojing Wei, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 10
Intranasal Lipid Nanoparticles Containing Bioactive Compounds Obtained from Marine Sources to Manage Neurodegenerative Diseases
Joana Torres, Inês Costa, Andreia F. Peixoto, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 2, pp. 311-311
Open Access | Times Cited: 5
Purinergic-associated immune responses in neurodegenerative diseases
Sara Carracedo, Agathe Launay, Paul-Alexandre Déchelle-Marquet, et al.
Progress in Neurobiology (2024) Vol. 243, pp. 102693-102693
Open Access | Times Cited: 1
The Multifaceted Role of GPCRs in Amyotrophic Lateral Sclerosis: A New Therapeutic Perspective?
Davide Bassani, Matteo Pavan, Stephanie Federico, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 4504-4504
Open Access | Times Cited: 6
Comparing the Characteristics of Microglia Preparations Generated Using Different Human iPSC-Based Differentiation Methods to Model Neurodegenerative Diseases
Ye Man Tang, Nisha S. Pulimood, Stefano Stifani
ASN NEURO (2022) Vol. 14, pp. 175909142211451-175909142211451
Open Access | Times Cited: 5
Advances on Cellular Clonotypic Immunity in Amyotrophic Lateral Sclerosis
Giuseppe Schirò, Vincenzo Di Stefano, Salvatore Iacono, et al.
Brain Sciences (2022) Vol. 12, Iss. 10, pp. 1412-1412
Open Access | Times Cited: 3
Prevalence of viral infections in MS and ALS
AISWARYA LAKSHMI A G, ATHIRADHA SB, FIDHA AV, et al.
International Journal of Frontiers in Science and Technology Research (2024) Vol. 6, Iss. 1, pp. 019-033
Open Access
Respiratory pathology in the TDP-43 transgenic mouse model of amyotrophic lateral sclerosis
Debolina D. Biswas, Ronit Sethi, Yochebed Woldeyohannes, et al.
Frontiers in Physiology (2024) Vol. 15
Open Access
Inhibition of SOD1 trimerization is a novel drug target for ALS disease
Tae‐Gyun Woo, Jin Han, Yuju Kim, et al.
Research Square (Research Square) (2024)
Closed Access
Potential Association between Methylmercury Neurotoxicity and Inflammation
Yo Shinoda, Masahiro Akiyama, Tadashi Toyama
Biological and Pharmaceutical Bulletin (2023) Vol. 46, Iss. 9, pp. 1162-1168
Open Access | Times Cited: 1
Depletion of perivascular macrophages delays ALS disease progression by ameliorating blood-spinal cord barrier impairment in SOD1G93A mice
Kazuki Adachi, Kota Miyata, Y Chida, et al.
Frontiers in Cellular Neuroscience (2023) Vol. 17
Open Access | Times Cited: 1
Comparison of Neuroinflammation Induced by Hyperphosphorylated Tau Protein Versus Ab42 in Alzheimer’s Disease
Madison Rice, Gerard J. Nuovo, Dwitiya Sawant, et al.
Molecular Neurobiology (2023) Vol. 61, Iss. 7, pp. 4589-4601
Closed Access | Times Cited: 1
Advances on Cellular Clonotypic Immunity in Amyotrophic Lateral Sclerosis
Giuseppe Schirò, Vincenzo Di Stefano, Filippo Brighina, et al.
(2022)
Open Access | Times Cited: 2
Insights on Natural Products Against Amyotrophic Lateral Sclerosis (ALS)
Kadja Luana Chagas Monteiro, Marcone Gomes dos Santos Alcântara, Thiago Mendonça de Aquino, et al.
Current Neuropharmacology (2023) Vol. 22, Iss. 7, pp. 1169-1188
Closed Access
T-Cell Aspects of Some Neurological Diseases
A. А. Kvichansky, Alexey P. Bolshakov
Neurochemical Journal (2023) Vol. 17, Iss. 4, pp. 691-701
Closed Access
T-Cell Aspects of Some Neurological Diseases
A. А. Kvichansky, Alexey P. Bolshakov
Нейрохимия (2023) Vol. 40, Iss. 4, pp. 423-434
Closed Access
Comparing the potential of microglia preparations generated using different human iPSC-based differentiation methods to model microglia-mediated mechanisms of amyotrophic lateral sclerosis pathophysiology
Ye Man Tang, Nisha S. Pulimood, Stefano Stifani
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Page 1

Scroll to top